Stanford Gynecologic Oncology Symposium (RECORDINGS)

Review the latest scientific advances in the field and bring together and encourage collaborative research with physicians and scientists throughout the world. The recorded symposium will present emerging research and advances in gynecologic oncology, with a focus on ovarian and breast cancer. Experts will explore topics including genetic testing, immunotherapy, organoid modeling, computational biology, and novel clinical trial data. Designed for oncology professionals, the activity will enhance understanding of the genomic landscape, therapeutic resistance, and precision medicine approaches. Attendees will gain actionable insights to support evidence-based treatment planning and improved patient outcomes in gynecologic oncology practice.

     Release Date: November 21, 2025

     Expiration Date: November 20, 2028

     Estimated Time to Complete: ~370 minutes

     Registration Fee: Free

*Originally recorded on 09/12/2025.

Click Begin to launch the activity.

1. Summarize recent advances in the genomic and molecular profiling of ovarian and other gynecologic cancers.
2. Evaluate the role and clinical application of immunotherapy, including CAR-T cell therapy, in gynecologic oncology.
3. Apply principles of precision medicine and genetic testing to the management of women’s cancers.
4. Discuss the relevance of organoid and computational models in cancer research and therapeutic development.
5. Identify clinical trial opportunities and strategies for addressing treatment resistance in gynecologic cancers.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Activity for a maximum of 6.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Enduring Activity for a maximum of 6.00 ANCC contact hours.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require visual, auditory, cognitive, or mobility accommodations, including dietary concerns, please contact the coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
View references and additional resources in the recordings.

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education. There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Oliver Dorigo, MD, PhD
Associate Professor, Director Division Gynecologic Oncology
SHC - Cancer Center

Course Director, Faculty

Consulting Fee-Blueprint Medicines (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Clovis (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-IMV (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-R-pharm (Relationship has ended)|Consulting Fee-PSI CRO Deutschland|Honoraria-AstraZeneca (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-GSK (Relationship has ended)|Speakers Bureau-Immunogern (Relationship has ended)|Grant or research support-AstraZeneca (Relationship has ended)|Grant or research support-IMV (Relationship has ended)|Grant or research support-Millennium Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Pharmamar (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)|Grant or research support-Bioeclipse|Grant or research support-Novartis AG (Relationship has ended)|Grant or research support-EMD Serono (Relationship has ended)

Steven Artandi, MD, PhD
Stanford University

Faculty

Nothing to disclose

Carolyn Bertozzi, PhD
Professor
Stanford University

Faculty

Nothing to disclose

Christopher Chen, MD
SHC

Faculty

Grant or research support-Rain Oncology|Other: Personal fees-Boxer Capital|Other: Personal fees-Globepoint Global Advisors|Other: Personal fees-Johnson and Johnson|Other: Personal fees-Mubadala Capital|Grant or research support-ADC Therapeutics|Grant or research support-ORIC Pharmaceuticals|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-Palleon Pharmaceuticals|Grant or research support-Pionyr Therapeutics|Grant or research support-Kinnate Biopharma|Grant or research support-Gilead|Grant or research support-Mersana Therapeutics|Grant or research support-Genentech Roche|Grant or research support-Biohaven Pharmaceuticals|Grant or research support-D3 Bio|Grant or research support-Merus|Grant or research support-Revolution Medicines|Grant or research support-Riboscience|Grant or research support-Tango Therapeutics

Edgar Engleman, MD
Professor of Pathology
Stanford University School of Medicine

Faculty

Nothing to disclose

Katherine Fuh, MD, PhD
Associate Professor, Director of Basic and Translational Research, Chair in Gynecologic Oncology
UCSF

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Corcept (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Abbvie (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Astra Zeneca (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyclix (Relationship has ended)

Brooke Elizabeth Howitt, MD
Faculty
Stanford University

Faculty

Consulting Fee-Tempus (Relationship has ended)|Honoraria-Leica (Relationship has ended)|Honoraria-Abbvie Immunogen (Relationship has ended)|Consulting Fee-Cartography|Grant or research support-Cartography|Grant or research support-Santa Ana Bio|Grant or research support-Link (Relationship has ended)|Honoraria-ACDBio (Relationship has ended)

Livnat Jerby, PhD, MSc
Assistant Professor of Genetics at Stanford University
Stanford University

Faculty

Nothing to disclose

Calvin Kuo, MD
Maureen Lyles D'Ambrogio Professor of Medicine (Hematology)
Stanford University

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Surrozen|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Mozart|Membership on Advisory Committees or Review Panels, Board Membership, etc.-NextVivo (Relationship has ended)|Grant or research support-Chugai|Ownership-Surrozen|Stock options in a privately held company-Mozart

Allison Walsh Kurian, MD, MSc, MSc
Professor of Medicine and of Epidemiology and Population HealthAssociate Chief, Division of OncologyCo-Leader, Population Sciences Program, Stanford Cancer InstituteDirector, Women’s Clinical Cancer Genetics Program
Stanford University School of Medicine

Faculty

Nothing to disclose

Crystal Lee Mackall, MD
Professor of Pediatrics (Hematology/Oncology) and of Medicine
Stanford University School of Medicine

Faculty

Paid consultant-CARGO Therapeutics (Relationship has ended)|Paid consultant-Immatics|Paid consultant-AstraZeneca|Paid consultant-Nektar|Paid consultant-Grace Science

Philip Anthony Pizzo, MD
Professor
Stanford Hospital & Clinics

Faculty

Nothing to disclose

Erinn Rankin, PhD
Associate Professor of Radiation Oncology and of Obstetrics and Gynecology- Oncology
Stanford University

Faculty

Nothing to disclose

Joellen Schildkraut, PhD, MPH, MPH
Professor of Epidemiology
Rollins School of Public Health, Emory University

Faculty

Nothing to disclose

Melinda Lee Telli, MD
Associate Professor of Medicine Stanford University Medical Center
SHC

Faculty

Consulting Fee-AstraZeneca|Consulting Fee-Blueprint Medicines|Consulting Fee-Daiichi Sankyo|Consulting Fee-Genentech, Inc.|Consulting Fee-Gilead|Consulting Fee-GlaxoSmithKline|Consulting Fee-G1 Therapeutics|Consulting Fee-Merck|Consulting Fee-Natera|Consulting Fee-Novartis AG|Consulting Fee-Pfizer, Inc.|Consulting Fee-Sanofi-Aventis|Grant or research support-Arvinas|Grant or research support-AstraZeneca|Grant or research support-Bayer Corporation|Grant or research support-Blueprint Medicines|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Grant or research support-GlaxoSmithKline|Grant or research support-Hummingbird Biosciences|Grant or research support-Merck|Grant or research support-OncoSec Medical|Grant or research support-Pfizer, Inc.|Consulting Fee-Arvinas|Consulting Fee-Cellcuity|Consulting Fee-Foresight Diagnostics|Consulting Fee-Eli Lilly and Company|Consulting Fee-Summit Therapeutics|Grant or research support-BioNTech

Jonathan Samuel Berek, MD, MMSc
Laurie Kraus Lacob Professor
Stanford University

Faculty, Planner

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc.|Grant or research support-Eisai, Inc.|Grant or research support-Karyopharm|Grant or research support-ImmunoGen|Grant or research support-Tesarao

Kristin Bixel, MD
Associate Professor
Stanford

Faculty, Reviewer

Nothing to disclose